Hua Medicine CEO Li Chen on Earnings
Share
Li Chen, Executive Director & CEO at Hua Medicine, discusses the Chinese biotech firm's growth plans exclusively on "Bloomberg: The China Show" following the company's first half results.
More from Australia
Capital battles heat up as takeover offers challenge listed housing operators
The equities fueling the next infrastructure supercycle
Crypto networks collide with sanctions in a fight for financial access
American Tungsten completes Nexus acquisition for Pinnacle MOU
Butn extends MYOB invoice financing agreement to 2027
Celsius Resources updates market on US$5M dispute